Stereotactic body-radiotherapy boost dose of 18 Gy vs 21 Gy in combination with androgen-deprivation therapy and whole-pelvic radiotherapy for intermediate- or high-risk prostate cancer: a study protocol for a randomized controlled, pilot trial

BACKGROUND: Combination therapy using external-beam radiotherapy (EBRT) with a brachytherapy boost has demonstrated superior biochemical control than dose-escalated EBRT alone. Whereas brachytherapy is disadvantageous because it is an invasive procedure, stereotactic body-radiotherapy (SBRT) using C...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yeon Joo, Ahn, Hanjong, Kim, Choung-Soo, Lee, Jae-Lyun, Kim, Young Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879839/
https://www.ncbi.nlm.nih.gov/pubmed/29609646
http://dx.doi.org/10.1186/s13063-018-2574-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879839/
https://www.ncbi.nlm.nih.gov/pubmed/29609646
http://dx.doi.org/10.1186/s13063-018-2574-y

Ejemplares similares